Four Vision Research and Treatment Trends to Watch in 2018
With the December 2017 announcement that the world’s first ocular gene therapy had received approval by the U.S. Food and Drug Administration (FDA), there’s no doubt that 2017 was a landmark year…
First gene therapy for a blinding eye disease receives FDA approval
Today we are celebrating the FDA’s pathbreaking approval of Luxturna. We have been following the development of Luxturna closely. Today’s landmark FDA approval makes Luxturna the first gene therapy approved in the…
The Value of iPSCs for Stem Cell Therapy
Stem cell therapy has emerged as one of the most promising approaches in the fight to end blindness, and Dr. Gilbert Bernier’s research has played an enormous role in pushing the field…
Clinician-Scientist Emerging Leader Award: Dr. Brian Ballios
Dr. Brian Ballios has restored vision in mice, but he is not stopping there. He is on a mission to develop stem cell therapies for people living with blindness and has a…
Will Gene Therapies Win the Race to Restore Sight?
There is a lot of optimism for the potential to treat inherited eye diseases with gene therapy. Around the world, scientists are exploring ways to fix the genetic errors that lead to…
How Can the FBC Help to Improve Your Vision Health Journey?
What is it like to live with a blinding eye disease in Canada? Do you have access to the vision care resources that you need? How can Fighting Blindness Canada (FBC) help…
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
